申请人:Onco Tartis Inc.
公开号:US10208032B2
公开(公告)日:2019-02-19
The present disclosure provides benzamide and nicotinamide compounds and pharmaceutical uses of the compounds. The compounds can be used to treat, for example, cancers such hematopoietic cancers (e.g., leukemia). The preferred compounds of the invention contain a phenylethynyl moiety as well as an amine-based heterocyclyl or heteroaryl moiety attached to the benzamide or nicotinamide compound.
本公开提供了苯甲酰胺和烟酰胺化合物及其药物用途。这些化合物可用于治疗癌症,例如造血癌症(如白血病)。本发明的优选化合物含有苯乙炔基以及连接到苯甲酰胺或烟酰胺化合物上的胺基杂环或杂芳基。